Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» dermatology
dermatology
FDA halts Sun Pharma's trials on dermatological drug
FDA halts Sun Pharma's trials on dermatological drug
Pharma Live
Sun Pharma
clinical trials
dermatology
deuruxolitinib
Flag link:
Medicxi backs siRNA-focused Aldena Therapeutics with $30M
Medicxi backs siRNA-focused Aldena Therapeutics with $30M
Endpoints
Aldena Therapeutics
Medicxi
siRNA
dermatology
Flag link:
Further shuffling at Leo Pharma as dermatology drugmaker splits R&D
Further shuffling at Leo Pharma as dermatology drugmaker splits R&D
Endpoints
LEO Pharma
R&D
dermatology
Flag link:
A small Connecticut biotech throws hat into IPO ring
A small Connecticut biotech throws hat into IPO ring
Endpoints
Azitra
IPOs
skin diseases
dermatology
Flag link:
Biosimilars hit a turning point as they expand outside oncology
Biosimilars hit a turning point as they expand outside oncology
Clinical Trials Arena
biosimilars
oncology
immunology
gastroenterology
ophthalmology
Respiratory
dermatology
metabolic disorders
musculoskeletal disorders
Flag link:
Boehringer Ingelheim finally has skin in the game, scoring its first dermatology FDA nod
Boehringer Ingelheim finally has skin in the game, scoring its first dermatology FDA nod
Fierce Pharma
Boehringer Ingelheim
FDA
dermatology
GPP
Spevigo
Flag link:
Dermatology biotech Krystal settles lawsuit from former partner as it prepares first FDA pitch
Dermatology biotech Krystal settles lawsuit from former partner as it prepares first FDA pitch
Endpoints
Krystal Biotech
dermatology
legal
PeriphaGen
gene therapy
Flag link:
Dermata Therapeutics prices ~$18M IPO
Dermata Therapeutics prices ~$18M IPO
Seeking Alpha
Dermata Therapeutics
dermatology
IPOs
Flag link:
Almirall kicks off another hunt for skin disease therapy partnerships
Almirall kicks off another hunt for skin disease therapy partnerships
Pharmaforum
Almirall
dermatology
R&D
Flag link:
LMC Manna Research Branches into Dermatology
LMC Manna Research Branches into Dermatology
CP WIre
LMC Manna
dermatology
clinical trials
CROs
Flag link:
LMC Manna Research Branches into Dermatology
LMC Manna
dermatology
clinical trials
CROs
Flag link:
AI drug discovery startup strikes partnership with LEO Pharma
AI drug discovery startup strikes partnership with LEO Pharma
MedCity News
Repurpose.AI
LEO Pharma
drug discovery
dermatology
Flag link:
Plug and Play aims to accelerate Almirall’s digital start-ups
Plug and Play aims to accelerate Almirall’s digital start-ups
Pharmaforum
dermatology
digital health
innovation
Almirall
Plug and Play
Flag link:
GlaxoSmithKline's spinoff plan is here—and it may not be limited to consumer health
GlaxoSmithKline's spinoff plan is here—and it may not be limited to consumer health
Fierce Pharma
GSK
spinoffs
Emma Walmsley
consumer health
dermatology
R&D
Flag link:
Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion
Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion
BioSpace
Eli Lilly
Dermira
dermatology
M&A
atopic dermatitis
Flag link:
Approval in sight, Perceptive, OrbiMed double down on Foamix's antibiotic foam to the tune of $64M
Approval in sight, Perceptive, OrbiMed double down on Foamix's antibiotic foam to the tune of $64M
Endpoints
FDA
Perceptive Advisors
OrbiMed
Foamix
dermatology
Flag link:
Probiotic Derived SkinBiotix Shows Efficacy in Increasing Skin Hydration
Probiotic Derived SkinBiotix Shows Efficacy in Increasing Skin Hydration
CP Wire
SkinBioTherapeutics
clinical trials
SkinBiotix
dermatology
Flag link:
Novartis first partner in RWE collaboration for dermatology
Novartis first partner in RWE collaboration for dermatology
BioCentury
Novartis
PharmaSolutions
real world evidence
dermatology
Flag link:
LEO Pharma and PellePharm Announce Collaboration to Advance Rare Skin Disease Therapies Worth up to $760 Million
LEO Pharma and PellePharm Announce Collaboration to Advance Rare Skin Disease Therapies Worth up to $760 Million
CP Wire
LEO Pharma
PellePharm
Gorlin Syndrome
dermatology
Flag link:
Lilly CMO Robert Brown to lead Brickell Bio as it eyes phase 3 dermatology trials
Lilly CMO Robert Brown to lead Brickell Bio as it eyes phase 3 dermatology trials
Fierce Biotech
Brickell Bio
Eli Lilly
Robert Brown
dermatology
Flag link:
Pages
1
2
3
4
next ›
last »